No longer trading

Acquired by Repligen Corporation

The acquisition closed on October 6, 2026 (SEC 8-K 2.01). Its last closing price was on October 5, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from October 5, 2026. Source: SEC 8-K 2.01

BLFS

BIOLIFE SOLUTIONS INC BLFS

NasdaqSmall CapHealthcare

Final 13F Pro quality score

Final rank #727 of 2,896 · as of October 5, 2026TOP 50%

Why it scores 62Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$28.47M

Quarter to Jun 30

Net income

$45.10M

Quarter to Jun 30

Free cash flow

$5.30M

Quarter to Jun 30

Operating margin

6.0%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$1.39B total
T. Rowe Price Investment Management, Inc.
$190.65M+3.8%
BlackRock, Inc.
$180.05M+4.5%
Casdin Capital, LLC
$131.46M-21.9%
Invesco Ltd.
$63.27M-4.6%
VANGUARD CAPITAL MANAGEMENT LLC
$55.47M+2.4%
STATE STREET CORP
$46.77M+5.0%
GEODE CAPITAL MANAGEMENT, LLC
$30.70M+11.8%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
$30.48M-9.9%
FRED ALGER MANAGEMENT, LLC
$30.43M-0.2%
DIMENSIONAL FUND ADVISORS LP
$29.55M+1.0%
FMR LLC
$28.05M-32.5%
BANK OF AMERICA CORP /DE/
$26.83M+5.1%
VANGUARD PORTFOLIO MANAGEMENT LLC
$25.79M+5.6%
ROYAL BANK OF CANADA
$25.16M+0.6%
UBS Group AG
$23.50M+212.9%
Stephens Investment Management Group LLC
$20.01M+5.3%
MILLENNIUM MANAGEMENT LLC
$17.67MNew
ROYCE & ASSOCIATES LP
$17.62M+6.8%
GENEVA CAPITAL MANAGEMENT LLC
$16.44M-21.3%
CRAMER ROSENTHAL MCGLYNN LLC
$16.26M-9.0%
NEXT CENTURY GROWTH INVESTORS LLC
$15.78M+54.4%
GAGNON SECURITIES LLC
$15.13M-0.1%
GOLDMAN SACHS GROUP INC
$15.01M+100.2%
Granahan Investment Management, LLC
$14.73M-27.8%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC
$14.02M-13.3%
See all 217 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/BLFS

Earnings Per Share

13fpro.ai/company/BLFS

Loading ratio trend…

BLFS insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in BLFS

2 transactions in BLFS reported by 1 member of Congress under the STOCK Act, most recent trade Dec 12, 2022. Reported transactions, not recommendations.

All Congress stock trades →

About BIOLIFE SOLUTIONS INC (BLFS): stock profile, AI score and financials

Acquired by Repligen Corporation: BIOLIFE SOLUTIONS INC (BLFS) no longer trades and has left 13F Pro's AI-ranked universe. The acquisition closed on October 6, 2026 (SEC 8-K 2.01). Its last closing price was on October 5, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from October 5, 2026. BIOLIFE SOLUTIONS INC (BLFS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro tracks BLFS using direct SEC EDGAR data and AI-powered research tools. Based on the latest XBRL financial filings (Q2 2026), BIOLIFE SOLUTIONS INC reports quarterly revenue of $28.5M, net income of $45.1M, an operating margin of 6.0%. BLFS trades on the Nasdaq exchange and files with the SEC under CIK 834365. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BLFS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BIOLIFE SOLUTIONS INC directly from SEC EDGAR.

SEC EDGAR: CIK 834365 →